Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting normal tissue injury in radiation therapy.

M Wollin1, A R Kagan, A Norman

  • 1Department of Radiation Therapy, Kaiser Permanente Medical Center, Los Angeles, CA 90027.

International Journal of Radiation Oncology, Biology, Physics
|October 1, 1991
PubMed
Summary

The linear quadratic (LQ) model shows promise in predicting normal tissue injury in radiation therapy, performing comparably or better than the nominal standard dose (NSD) model. While no model perfectly predicted all injuries, LQ demonstrated significant predictive capabilities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Measurement of Neutrino Oscillation Parameters with 10 Years of Data from the NOvA Experiment.

Physical review letters·2026
Same author

Dual-Baseline Search for Active-to-Sterile Neutrino Oscillations in NOvA.

Physical review letters·2025
Same author

Search for CP-Violating Neutrino Nonstandard Interactions with the NOvA Experiment.

Physical review letters·2024
Same author

Measurement of the ν_{e}-Nucleus Charged-Current Double-Differential Cross Section at ⟨E_{ν}⟩=2.4  GeV Using NOvA.

Physical review letters·2023
Same author

Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC.

The European physical journal. C, Particles and fields·2022
Same author

Search for Active-Sterile Antineutrino Mixing Using Neutral-Current Interactions with the NOvA Experiment.

Physical review letters·2021

Area of Science:

  • Radiation oncology
  • Radiobiology
  • Clinical outcomes research

Background:

  • Accurate prediction of normal tissue injury is crucial in radiation therapy to optimize treatment efficacy and minimize toxicity.
  • Several radiobiologic models exist to predict treatment outcomes, but their clinical applicability varies.

Purpose of the Study:

  • To compare the predictive accuracy of three radiobiologic models—nominal standard dose (NSD), biologic index of reaction (BIR), and linear quadratic (LQ)—for normal tissue injury in radiation therapy.
  • To determine which model best predicts clinical outcomes such as radiation myelopathy, rib fracture, and pericardial effusion.

Main Methods:

  • Clinical data from patients experiencing specific normal tissue injuries were analyzed using the NSD, BIR, and LQ models.
  • A t-test was employed to assess significant differences in equivalent radiation doses between injured and non-injured patient groups.

Related Experiment Videos

  • The LQ model's sensitivity to the alpha/beta parameter was evaluated across a range of 1/2 to 12 Gy.

    • Main Results:

    • None of the models demonstrated statistically significant differences between injured and non-injured patients across all four injury datasets.
    • The BIR model achieved significance in three datasets, while the LQ and NSD models were significant in two datasets each.
    • The LQ model showed marginal significance in one additional dataset, indicating a potential advantage over the NSD model.

    Conclusions:

    • The linear quadratic (LQ) model is a viable option for analyzing clinical data in radiation therapy, offering results comparable or superior to the nominal standard dose (NSD) model.
    • Further validation is needed, but the LQ model shows potential for improved prediction of normal tissue complications.
    • The study highlights the ongoing need for robust radiobiologic models to guide clinical decision-making in radiation oncology.